共 50 条
- [1] A DOUBLE-BLIND CONTROLLED TRIAL OF HIGH-DOSE METHYLPREDNISOLONE IN PATIENTS WITH MULTIPLE-SCLEROSIS .1. CLINICAL EFFECTS [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1987, 50 (05): : 511 - 516
- [2] A DOUBLE-BLIND CONTROLLED TRIAL OF HIGH-DOSE METHYLPREDNISOLONE IN PATIENTS WITH MULTIPLE-SCLEROSIS .2. LABORATORY RESULTS [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1987, 50 (05): : 517 - 522
- [3] A DOUBLE-BLIND CONTROLLED TRIAL OF HIGH-DOSE METHYL PREDNISOLONE IN MULTIPLE-SCLEROSIS [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1988, 51 (02): : 316 - 316
- [5] A DOUBLE-BLIND CONTROLLED TRIAL OF HIGH-DOSE INTRAVENOUS METHYL PREDNISOLONE IN THE TREATMENT OF MULTIPLE-SCLEROSIS [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1986, 49 (04): : 478 - 478
- [6] DOUBLE-BLIND, CONTROLLED TRIAL OF IMMUNOSUPPRESSION IN TREATMENT OF MULTIPLE-SCLEROSIS [J]. LANCET, 1980, 2 (8201): : 949 - 951
- [7] RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL OF CYCLOSPORINE IN MULTIPLE-SCLEROSIS [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (05): : 559 - 565
- [8] DOUBLE-BLIND CONTROLLED TRIAL OF AZATHIOPRINE IN THE TREATMENT OF MULTIPLE-SCLEROSIS [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1987, 50 (10): : 1387 - 1387
- [10] Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial [J]. LANCET, 2015, 386 (9997): : 974 - 981